Krishna Institute of Medical Sciences Limited (KIMS.NS)
- Previous Close
634.50 - Open
611.00 - Bid --
- Ask --
- Day's Range
610.00 - 637.00 - 52 Week Range
350.00 - 708.00 - Volume
332,045 - Avg. Volume
744,410 - Market Cap (intraday)
254.148B - Beta (5Y Monthly) -0.11
- PE Ratio (TTM)
73.09 - EPS (TTM)
8.69 - Earnings Date May 12, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
692.23
Krishna Institute of Medical Sciences Limited provides medical and health care services under the KIMS Hospitals brand name in India. The company offers range of specialties, including cardiac, dental, neuro, oncological, orthopedic, renal, reproductive, and robotic sciences, as well as gastroenterology and hepatology, heart and lung transplant, organ transplantation, mother and childcare, and pediatrics services. It focuses on accident, biochemistry, anesthesiology, bariatric surgery, andrology and infertility, arthroscopy, Alzheimer's, bone, joint center specialties, and others. In addition, the company provides medical procedures for aneurysm, ankle arthritis and total ankle replacement, anterior cervical discectomy and fusion surgery, anterior resection, aortic aneurysm, aortic stent graft, aortic valve replacement, arthroscopy, atrial septal defect, bariatric surgery, and others. Krishna Institute of Medical Sciences Limited was incorporated in 1973 and is based in Secunderabad, India.
www.kimshospitals.com5,013
Full Time Employees
March 31
Fiscal Year Ends
Sector
Industry
Recent News: KIMS.NS
View MorePerformance Overview: KIMS.NS
Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: KIMS.NS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: KIMS.NS
View MoreValuation Measures
Market Cap
253.49B
Enterprise Value
269.90B
Trailing P/E
72.85
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
8.90
Price/Book (mrq)
12.68
Enterprise Value/Revenue
9.48
Enterprise Value/EBITDA
34.87
Financial Highlights
Profitability and Income Statement
Profit Margin
12.12%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
28.72B
Net Income Avi to Common (ttm)
3.48B
Diluted EPS (ttm)
8.69
Balance Sheet and Cash Flow
Total Cash (mrq)
902M
Total Debt/Equity (mrq)
78.07%
Levered Free Cash Flow (ttm)
--